Clinical Trial Update: Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effectiveness and safety of topical ranibizumab for corneal neovascularization has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Reza Dana, MD | Conditions: Corneal Neovascularization | Phase 1 | Status: COMPLETED | Results posted: 2012-11-08